Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Femtogenix

Femtogenix?uq=PEM9b6PF
2015 FOUNDED
PRIVATE STATUS
Series A LATEST DEAL TYPE
$3.52M LATEST DEAL AMOUNT
1 INVESTORS
Description

Developer of next generation DNA-interactive payload molecules designed to treat cancer. The company's DNA-interactive payload molecules are designed in a sequence-interactive manner through a development platform combining computational chemistry techniques, enabling cancer patients to access cytototoxic agents with minimal general systemic toxicities.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Other Pharmaceuticals and Biotechnology
Primary Office
  • BioPark
  • Broadwater Road
  • Welwyn Garden City AL7 3AX
  • England

+44 020 0000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Femtogenix’s full profile, request a free trial.

Femtogenix Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 19-Oct-2015 $3.52M 00.000 00.000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Femtogenix Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
To view this company’s complete Cap Table, request access »

Femtogenix Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Research Corporation Technologies Venture Capital Minority 000 0000 000000 0

Femtogenix Executive Team (5)

Name Title Board
Seat
Contact
Info
Shaun Kirkpatrick Director
Christopher Keightley Ph.D Board Member & Chief Executive Officer
David Thurston Ph.D Co-Founder, Board Member & Chief Scientific Officer
Khondaker Rahman Ph.D Co-Founder & Chemistry & Biology Consultant
Paul Jackson Ph.D Co-Founder, Computational Chemist & Project Manager

Femtogenix Board Members (3)

Name Representing Role Since Contact
Info
Christopher Keightley Ph.D Self Board Member & Chief Executive Officer 000 0000
David Thurston Ph.D Self Co-Founder, Board Member & Chief Scientific Officer 000 0000
Keith Brennan Femtogenix Board Member 000 0000